Bristol Myers Squibb EPS - Earnings per Share 2010-2022 | BMY
Bristol Myers Squibb annual and quarterly earnings per share history from 2010 to 2022. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Bristol Myers Squibb EPS for the quarter ending March 31, 2022 was $0.59, a 33.71% decline year-over-year.
- Bristol Myers Squibb EPS for the twelve months ending March 31, 2022 was $2.82, a 202.17% decline year-over-year.
- Bristol Myers Squibb 2021 annual EPS was $3.12, a 178.2% decline from 2020.
- Bristol Myers Squibb 2020 annual EPS was $-3.99, a 298.51% decline from 2019.
- Bristol Myers Squibb 2019 annual EPS was $2.01, a 33.22% decline from 2018.
| Bristol Myers Squibb Annual EPS |
| 2021 |
$3.12 |
| 2020 |
$-3.99 |
| 2019 |
$2.01 |
| 2018 |
$3.01 |
| 2017 |
$0.61 |
| 2016 |
$2.65 |
| 2015 |
$0.93 |
| 2014 |
$1.20 |
| 2013 |
$1.54 |
| 2012 |
$1.16 |
| 2011 |
$2.16 |
| 2010 |
$1.79 |
| 2009 |
$5.34 |
| Bristol Myers Squibb Quarterly EPS |
| 2022-03-31 |
$0.59 |
| 2021-12-31 |
$1.07 |
| 2021-09-30 |
$0.69 |
| 2021-06-30 |
$0.47 |
| 2021-03-31 |
$0.89 |
| 2020-12-31 |
$-4.43 |
| 2020-09-30 |
$0.82 |
| 2020-06-30 |
$-0.04 |
| 2020-03-31 |
$-0.34 |
| 2019-12-31 |
$-0.73 |
| 2019-09-30 |
$0.83 |
| 2019-06-30 |
$0.87 |
| 2019-03-31 |
$1.04 |
| 2018-12-31 |
$0.71 |
| 2018-09-30 |
$1.16 |
| 2018-06-30 |
$0.23 |
| 2018-03-31 |
$0.91 |
| 2017-12-31 |
$-1.40 |
| 2017-09-30 |
$0.51 |
| 2017-06-30 |
$0.56 |
| 2017-03-31 |
$0.94 |
| 2016-12-31 |
$0.53 |
| 2016-09-30 |
$0.72 |
| 2016-06-30 |
$0.69 |
| 2016-03-31 |
$0.71 |
| 2015-12-31 |
$-0.12 |
| 2015-09-30 |
$0.42 |
| 2015-06-30 |
$-0.08 |
| 2015-03-31 |
$0.71 |
| 2014-12-31 |
$0.01 |
| 2014-09-30 |
$0.43 |
| 2014-06-30 |
$0.20 |
| 2014-03-31 |
$0.56 |
| 2013-12-31 |
$0.43 |
| 2013-09-30 |
$0.42 |
| 2013-06-30 |
$0.32 |
| 2013-03-31 |
$0.37 |
| 2012-12-31 |
$0.57 |
| 2012-09-30 |
$-0.43 |
| 2012-06-30 |
$0.38 |
| 2012-03-31 |
$0.64 |
| 2011-12-31 |
$0.51 |
| 2011-09-30 |
$0.56 |
| 2011-06-30 |
$0.52 |
| 2011-03-31 |
$0.57 |
| 2010-12-31 |
$0.28 |
| 2010-09-30 |
$0.55 |
| 2010-06-30 |
$0.53 |
| 2010-03-31 |
$0.43 |
| 2009-12-31 |
$4.05 |
| 2009-09-30 |
$0.48 |
| 2009-06-30 |
$0.49 |
| 2009-03-31 |
$0.32 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$163.299B |
$46.385B |
|
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
|
